Compare OLMA & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | HBT |
|---|---|---|
| Founded | 2006 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2019 |
| Metric | OLMA | HBT |
|---|---|---|
| Price | $10.90 | $35.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $44.89 | $30.75 |
| AVG Volume (30 Days) | ★ 993.2K | 128.8K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | ★ 15.00 | 7.96 |
| EPS | N/A | ★ 1.12 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $35.73 |
| Revenue Next Year | N/A | $7.01 |
| P/E Ratio | ★ N/A | $31.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.36 | $22.36 |
| 52 Week High | $36.26 | $37.51 |
| Indicator | OLMA | HBT |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 53.32 |
| Support Level | $10.71 | $35.34 |
| Resistance Level | $12.37 | $36.83 |
| Average True Range (ATR) | 0.59 | 0.79 |
| MACD | -0.04 | -0.24 |
| Stochastic Oscillator | 44.62 | 20.16 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking. It generates revenue from Card income, Wealth management fees, and Service charges on deposit accounts.